Interferon alfa-2a
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), National Taiwan University Hospital, Foundation for Liver Research, University Hospital, Geneva, Gruppo Oncologico Italiano di Ricerca Clinica
Conditions
AdenocarcinomaAnus NeoplasmsBehçet DiseaseCancerCarcinomaCarcinoma, Renal CellChronic Hepatitis CEnd Stage Renal Disease
Phase 1
A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
CompletedNCT00000696
End: 1993-11-30Target: 48Updated: 2021-11-02
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
CompletedNCT00000764
End: 1996-07-31Target: 98Updated: 2021-10-28
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
CompletedNCT00001113
End: 1990-03-31Target: 48Updated: 2021-11-04
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
CompletedNCT00000725
End: 1990-02-28Target: 56Updated: 2021-11-03
The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
CompletedNCT00000967
End: 1996-09-30Target: 52Updated: 2021-10-29
Phase 2
A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
CompletedNCT00000754
End: 1995-02-28Target: 60Updated: 2021-11-04
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
CompletedNCT00000687
End: 1993-07-31Target: 60Updated: 2021-11-03
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
CompletedNCT00008463
Start: 2000-11-30End: 2006-08-31Target: 132Updated: 2021-11-01
Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
CompletedNCT00433069
Start: 2007-01-31End: 2008-01-31Updated: 2015-05-28
A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.
CompletedNCT00520403
Start: 2007-09-30End: 2010-03-31Updated: 2014-10-13
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
CompletedNCT00719264
Start: 2008-11-12End: 2013-04-15Updated: 2017-03-20
A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).
CompletedNCT00796757
Start: 2008-12-31End: 2012-02-29Updated: 2015-05-27
Pilot Study of Interferon Alfa for Patients Who Have Received Cancer Vaccines
TerminatedNCT02159482
Start: 2005-11-30End: 2008-05-31Updated: 2014-07-25
Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection
CompletedNCT02340962
Start: 2015-05-31End: 2016-10-26Updated: 2023-07-14
Phase 3
High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV
CompletedNCT00381953
Start: 2003-02-28End: 2006-07-31Updated: 2021-09-01
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
CompletedNCT00502034
Start: 1994-07-31End: 2012-06-30Updated: 2013-07-10
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
CompletedNCT03209219
Start: 2017-06-30End: 2021-01-31Updated: 2021-02-23